763 related articles for article (PubMed ID: 28796371)
1. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
2. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
4. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
5. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
[TBL] [Abstract][Full Text] [Related]
6. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
[TBL] [Abstract][Full Text] [Related]
7. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
8. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
11. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
Florin TH; Pandeya N; Radford-Smith GL
Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646
[TBL] [Abstract][Full Text] [Related]
14. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
16. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
[TBL] [Abstract][Full Text] [Related]
17. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
19. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
[TBL] [Abstract][Full Text] [Related]
20. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
